New drug combo shows promise against rare liver virus
Disease control
Ongoing
This study tests two experimental drugs, VIR-2218 and VIR-3434, in about 95 adults with chronic hepatitis D, a serious liver infection. The goal is to see if the drugs can lower the virus to undetectable levels and improve liver function. Participants must have had hepatitis D fo…
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC